Date Filed | Type | Description |
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/11/2023 |
SC 13D/A
| UAW Retiree Medical Benefits Trust reports a 99.1% stake in 21, INC. |
08/10/2023 |
40-APP/A
| Form 40-APP/A - Application for exemption and other relief filed under the Investment Company Act of 1940: [Amend] |
07/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/09/2023 |
40-APP/A
| Form 40-APP/A - Application for exemption and other relief filed under the Investment Company Act of 1940: [Amend] |
05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
04/26/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/24/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
03/02/2023 |
SC 13D/A
| UAW Retiree Medical Benefits Trust reports a 99% stake in 21, INC. |
01/25/2023 |
SC 13D/A
| UAW Retiree Medical Benefits Trust reports a 99% stake in 21, INC. |
01/24/2023 |
8-K
| Quarterly results |
12/15/2022 |
8-K
| Unregistered Sales of Equity Securities Interactive Data |
12/13/2022 |
SC 13D/A
| UAW Retiree Medical Benefits Trust reports a 99% stake in 21, INC. |
11/21/2022 |
40-17G
| Form 40-17G - Fidelity Bond [Rule 17G-1(g)]: |
11/04/2022 |
8-K
| Quarterly results |
10/20/2022 |
8-K
| Quarterly results |
10/18/2022 |
SC 13D/A
| UAW Retiree Medical Benefits Trust reports a 99% stake in 21, INC. |
10/03/2022 |
40-APP
| Form 40-APP - Application for exemption and other relief filed under the Investment Company Act of 1940: |
08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
07/28/2022 |
8-K
| Quarterly results |
07/05/2022 |
8-K
| Quarterly results |
06/29/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/21/2022 |
8-K
| Quarterly results |
05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
04/29/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/10/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
03/03/2022 |
8-K
| Quarterly results |
12/22/2021 |
8-K
| Quarterly results |
12/21/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/21/2021 |
40-17G
| Form 40-17G - Fidelity Bond [Rule 17G-1(g)]: |
12/16/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
11/15/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
10/12/2021 |
8-K
| Quarterly results |
|